Background Invasive aspergillosis (IA) is a life‐threatening opportunistic mycosis that occurs
in some people with a compromised immune system. The serum galactomannan enzyme …

Background Invasive aspergillosis is the most common life‐threatening opportunistic
invasive mycosis in immunocompromised patients. A test for invasive aspergillosis should …

Background Bronchoalveolar lavage (BAL) galactomannan (GM) assay has been used for
diagnosing invasive aspergillosis (IA). We aimed to derive a definitive estimate of the overall …

Background A serum galactomannan (GM) assay has been approved for diagnosing
invasive aspergillosis (IA). However, the role of the BAL-GM assay has not been well …

Background A clear cutoff value of galactomannan (GM) has not been established for
chronic pulmonary aspergillosis (CPA) and is frequently extrapolated from invasive …

Objectives Bronchoalveolar lavage galactomannan (BAL‐GM) is a mycological criterion for
diagnosis of probable invasive aspergillosis (IA) per European Organization for Research …

Background. A double-sandwich enzyme-linked immunosorbent galactomannan assay has
been approved for surveillance for invasive aspergillosis in immunocompromised patients …

Background The role of galactomannan (GM) in serum or bronchoalveolar lavage fluid
(BALF) for the diagnosis of invasive pulmonary aspergillosis (IPA) has been extensively …

Background: The clinical utility of bronchoalveolar lavage (BAL) fluid galactomannan (GM)
for the early diagnosis of invasive aspergillosis (IA) varies widely across studies mainly due …

Galactomannan (GM) testing of bronchoalveolar lavage (BAL) fluid samples has become an
essential tool to diagnose invasive pulmonary aspergillosis (IPA) and is part of diagnostic …